ADC Therapeutics

adctherapeutics.com

Industry
Pharma & biotech
Headquarters
Épalinges, Vaud
Type
listed
Employees (approx.)
250
Checked on
19 October 2026
51/100Grade C

Protection against forged senders: not protected (monitoring only)

Points per criterion

  • MX 10 / 10
  • SPF 15 / 15
  • DKIM 20 / 20
  • DMARC 6 / 25
  • DNSSEC 0 / 10
  • Transport (MTA-STS/DANE) 0 / 15
  • TLS-RPT 0 / 5

Findings

  • ✕DMARC in monitoring mode only (p=none)

    p=none provides reports but does not reject a single forgery. The goal is p=reject.

  • !DKIM key below 2048 bits

    RSA-1024 is considered too weak (RFC 8301, M3AAWG). Rotate to 2048-bit keys.

  • !DNSSEC not enabled

    Without DNSSEC, DNS answers can be forged in transit. DANE requires DNSSEC.

  • !No MTA-STS

    Without MTA-STS (or DANE) inbound encryption is not enforced; an attacker on the path can downgrade to plain text.

  • !No TLS reporting (TLS-RPT)

    Without TLS-RPT the organisation does not learn when senders fail to deliver encrypted.

Check live in the Mail DNS Check →

Who runs the mail?

Mailbox provider
Microsoft 365
Upstream gateway
Mimecast
Provider jurisdiction
USA · MX: US
Detection confidence
99 / 100
Microsoft tenant
Managed · ADC Therapeutics
Tenant region
NA
Signals (5)
SPFMicrosoft 365include:spf.protection.outlook.com
DKIMMicrosoft 365selector1 → selector1-adctherapeutics-com._domainkey.adctsa.onmicrosoft.com
AutodiscoverMicrosoft 365autodiscover.outlook.com
Domain verificationGoogle Workspacegoogle-site-verification=9Xa5DWCxZuj0RF4
Entra IDMicrosoft 365Entra-ID-Tenant (Managed)

MX servers

PrefHostIPNetworkCountryTLSA
10 us-smtp-inbound-1.mimecast.com 170.10.132.221 AS30031 MIMECAST-US - Mimecast North America Inc US –
170.10.128.242 AS30031 MIMECAST-US - Mimecast North America Inc US
170.10.132.141 AS30031 MIMECAST-US - Mimecast North America Inc US
10 us-smtp-inbound-2.mimecast.com 170.10.132.141 AS30031 MIMECAST-US - Mimecast North America Inc US –
170.10.128.141 AS30031 MIMECAST-US - Mimecast North America Inc US
170.10.132.242 AS30031 MIMECAST-US - Mimecast North America Inc US

SPF

v=spf1 include:us._netblocks.mimecast.com ip4:52.29.180.68 ip4:85.218.101.138 include:spf.protection.outlook.com include:_spf.salesforce.com -all
all
-all
DNS lookups
4 / 10
Includes
us._netblocks.mimecast.comspf.protection.outlook.com_spf.salesforce.com
Detected sending services
Mimecast, Microsoft 365, Salesforce
IPv4
2 addresses authorised directly

DMARC

v=DMARC1;p=none;rua=mailto:0fc3b37c97@rua.easydmarc.us;ruf=mailto:0fc3b37c97@ruf.easydmarc.us;fo=1;
Policy
p=none
Subdomains (sp)
inherits p=none
Share (pct)
100 %
Alignment DKIM/SPF
relaxed / relaxed
Aggregate reports (rua)
0fc3b37c97@rua.easydmarc.us
Forensic reports (ruf)
0fc3b37c97@ruf.easydmarc.us
Report services
EasyDMARC

DKIM

SelectorKeydelegated to
s1 RSA 2048 s1.domainkey.u19474700.wl201.sendgrid.net
s2 RSA 1024 s2.domainkey.u19474700.wl201.sendgrid.net
selector1 RSA 2048 selector1-adctherapeutics-com._domainkey.adctsa.onmicrosoft.com

Checked: 100 common selectors. Keys under custom selectors remain invisible.

Transport encryption

MTA-STS
missing
DANE
missing
DNSSEC
missing
TLS-RPT
missing
BIMI
missing

Verified services

From verification records in the domain TXT: services where the domain is verified.

GoogleAppleZoom

History

  • Score 51 · DMARC none

All changes of this organisation in the change log →

Raw data
adctherapeutics.com. IN MX 10 us-smtp-inbound-1.mimecast.com.
adctherapeutics.com. IN MX 10 us-smtp-inbound-2.mimecast.com.
adctherapeutics.com. IN TXT "v=spf1 include:us._netblocks.mimecast.com ip4:52.29.180.68 ip4:85.218.101.138 include:spf.protection.outlook.com include:_spf.salesforce.com -all"
_dmarc.adctherapeutics.com. IN TXT "v=DMARC1;p=none;rua=mailto:0fc3b37c97@rua.easydmarc.us;ruf=mailto:0fc3b37c97@ruf.easydmarc.us;fo=1;"

More from this industry

← Back to overview